RKIPによるRaf-1キナーゼ活性とMAPキナーゼシグナル伝達の抑制
1Brown University, Department of Molecular Biology, Cell Biology and Biochemistry, Richmond 02912, USA.
Nature
|September 18, 1999
まとめ
新しく発見されたラフキナーゼ阻害タンパク質 (RKIP) は,細胞の成長と分化を調節する. RKIPはRaf/MEK/ERK経路を阻害し,細胞の増殖と分化を制御するための新しいターゲットを提供します.
科学分野:
- 細胞生物学 細胞生物学
- 分子生物学は分子生物学である.
- バイオケミストリー バイオケミストリー
背景:
- Raf/MEK/ERKキナーゼカスケードは,細胞の増殖と分化を調節するために重要である.
- Raf-1キナーゼはMEK-1を活性化させ,それが細胞外信号調節キナーゼ (ERK) を活性化します.
研究 の 目的:
- Raf/MEK/ERKシグナル伝達経路の新たなレギュレータを特定し,特徴づけること.
- キナーゼ調節における,新たに特定されたRaf-1相互作用タンパク質であるRKIPの役割を調査する.
主な方法:
- イースト2ハイブリッドスクリーニングで,Raf-1相互作用タンパク質を特定します.
- RKIPの相互作用を研究するために,インビトロ結合アッセイ,共免疫プレシピテーション,およびコンフォカル顕微鏡検査を行いました.
- 細胞シグナル伝達におけるRKIP機能を評価するための過剰発現と反センセスのRNA研究.
主要な成果:
- Raf-1,MEK,ERKに結合する新しいタンパク質,Rafキナーゼ阻害タンパク質 (RKIP) が特定されました.
- RKIPはRaf-1-媒介によるMEKのリン酸化と活性化を阻害し,MEK/ERKカスケードを妨害する.
- RKIPの過剰発現はMEK/ERKの活性化と下流転写イベントを抑制し,RKIPのダウンレギュレーションはそれらを強化する.
結論:
- RKIPは,Raf/MEK/ERK経路を否定的に調節する新しいタンパク質キナーゼ阻害剤です.
- RKIPは,この重要なシグナリングモジュールの活動を制御する新しいクラスの阻害剤を表しています.
- RKIPをターゲットにすることで,異常な細胞の増殖と分化を含む疾患の治療戦略を提供することができる.
関連する概念動画
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
01:26Receptor Tyrosine Kinases
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
01:24Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...